U.S. Pharma Stock News

Earlier this month, Norwegian Cruise Line Holdings announced it had confirmed a newbuild order with Fincantieri to construct a third Prestige-Class vessel for its Regent Seven Seas Cruises brand, set for delivery in 2033, following the debut of two sister ships in 2026 and 2030. This move underscores the company’s ongoing expansion in the ultra-luxury cruise market, featuring Regent’s first new ship class in a decade with larger designs and elevated guest experiences. We'll now examine how...

Sirius XM Holdings recently reported its third quarter 2025 results, showing a swing to US$297 million net income from a very large net loss a year ago, although revenue edged slightly lower to US$2.16 billion for the quarter. The company also completed the latest share buyback tranche, repurchasing over 860,000 shares for US$19.63 million, signaling continued commitment to shareholder returns alongside improved profitability. We'll explore how Sirius XM Holdings' return to profitability and...

ZenaTech (NasdaqCM:ZENA) just reported record revenue growth this quarter, largely fueled by its fast-growing Drone as a Service operations both in the US and internationally. Investors are eyeing the company’s ongoing expansion efforts as well as its growing industry partnerships. See our latest analysis for ZenaTech. This string of major announcements, including record-setting revenue growth, new manufacturing sites in the UAE, and high-profile industry partnerships, has put ZenaTech firmly...

Compass (COMP) shares have drawn attention following a strong rally over the past month, gaining nearly 37% in that period. Investors are now considering how recent trading activity reflects the company’s underlying value. See our latest analysis for Compass. Compass has seen momentum build as its share price return hit 63.8% year-to-date, with fresh gains over the past week confirming renewed investor interest. Looking at the bigger picture, its three-year total shareholder return of 209.5%...

CNO Financial Group (CNO) surprised the market this quarter by posting results that beat expectations on both earnings and revenue. Alongside the strong report, the company declared a $0.17 per share dividend, signaling continued focus on shareholder returns. See our latest analysis for CNO Financial Group. CNO Financial Group’s strong third-quarter results, dividend boost, and ongoing buybacks have spurred renewed investor interest, with momentum clearly building. The stock’s 12%...

Kenvue (KVUE) shares have seen a slight uptick over the past week, gaining just over 2%. Investors are taking stock of the company’s recent performance and weighing its valuation against longer-term trends. See our latest analysis for Kenvue. Kenvue’s share price has struggled to build momentum in recent months, with a 1-year total shareholder return of -24.98%. Continued weakness persists despite a small bounce this week. Investors seem cautious as the longer-term downward trend continues to...

Firefly Aerospace recently provided full-year 2025 revenue guidance of US$150 million to US$158 million, while also facing heightened legal scrutiny following a class action lawsuit alleging misleading statements in its IPO disclosures and recent operational challenges. The company simultaneously amended its credit agreement to boost financial flexibility and address liquidity needs, highlighting the intersection of financial maneuvering and investor concerns. We’ll explore how legal...

Booz Allen Hamilton Holding (BAH) has moved lower over the past month, with shares declining nearly 12%. Despite the slide, the stock remains an interesting follow for those watching government consulting names, especially given its steady revenue. See our latest analysis for Booz Allen Hamilton Holding. This continued slide comes after a tough year for Booz Allen Hamilton Holding, as momentum has faded following a long stretch of steady revenue. The 1-year total shareholder return is down...

Saia (SAIA) just released its third-quarter results, revealing a small dip in sales and profit compared to last year. However, the outlook remains upbeat. Analysts recently bumped up their estimates for 2025 earnings. See our latest analysis for Saia. Saia’s performance over the past year has been rocky, with its share price sliding nearly 36% since January and its one-year total shareholder return dropping 47%. However, recent upward earnings estimate revisions and analyst confidence suggest...

United Therapeutics recently announced the first clinical xenotransplantation in its EXPAND study, where a UKidney™ was successfully transplanted into a patient with end-stage renal disease at NYU Langone Health. This achievement not only advances transplant medicine but also signals a potential paradigm shift for patients on kidney transplant waiting lists, as the study aims to enable broader access through innovative organ manufacturing solutions. We'll examine how the successful first...

Viper Energy recently reported its third quarter 2025 results, highlighting a significant year-over-year revenue increase to US$418 million, alongside a net loss of US$77 million and confirmation of continued share buybacks and dividend payments. Despite substantially higher revenues, investors’ focus is likely on the swing from profit to loss, fresh production guidance, and the company's completion of a major share repurchase program. We'll explore how Viper Energy's substantial buyback...

Brown-Forman (NYSE:BF.B) is making a move into the U.S. ready-to-drink cocktail scene with the launch of New Mix, Mexico’s leading tequila-based RTD. The rollout reflects a strategy shift to meet changing consumer tastes and reinvigorate growth. See our latest analysis for Brown-Forman. While momentum has faded, Brown-Forman’s 1-year total shareholder return sits at -30.66% and shares have lost over a quarter of their value year-to-date. This new launch signals a strategic pivot that could...

Ascendis Pharma (NasdaqGS:ASND) has caught the attention of investors, with shares fluctuating over the past month. The company’s stock performance reflects shifts in sentiment as market participants consider recent fundamentals and growth metrics. See our latest analysis for Ascendis Pharma. Over the past year, Ascendis Pharma has demonstrated solid momentum, with a year-to-date share price return of 44.36% and a striking 58.07% total shareholder return for the year. Recent price swings...

Palantir Technologies (PLTR) shares have seen modest movement this week, as investors weigh recent trading results and consider longer-term performance trends. The company has delivered strong revenue and net income growth over the past year, drawing continued interest from the market. See our latest analysis for Palantir Technologies. After an impressive run in 2024, Palantir’s share price has taken a breather in the past week, but the bigger picture still looks strong. While the 1-day and...

HA Sustainable Infrastructure Capital (HASI) just posted its most profitable quarter ever, with revenue and net income both jumping sharply from last year. The company also highlighted a $1.2 billion investment in the SunZia clean energy project, strengthening its forward-looking growth guidance. See our latest analysis for HA Sustainable Infrastructure Capital. Momentum has picked up for HA Sustainable Infrastructure Capital in recent months, partly due to its best-ever quarterly earnings...

East West Bancorp (EWBC) recently posted third-quarter results that beat expectations on both earnings per share and revenue, which has sparked attention from investors. The upbeat performance and analyst support are fueling fresh interest in the stock. See our latest analysis for East West Bancorp. Strong third-quarter results have helped drive positive momentum for East West Bancorp, with the share price up over 11% year-to-date. The company’s three- and five-year total shareholder returns...

Immunovant (IMVT) grabbed investor attention after releasing its latest earnings, reporting a quarterly loss per share that came in better than anticipated. At the same time, updates on key drug studies gave observers plenty to consider. See our latest analysis for Immunovant. Immunovant’s 35.1% 1-month share price return stands out, particularly following positive clinical updates and a quarterly loss that beat expectations. Despite this short-term momentum, its total shareholder return over...

On November 12, 2025, Barclays initiated coverage on Penske Automotive Group, assigning an "Overweight" rating under analyst John Babcock. This coverage highlights institutional confidence in Penske’s global dealership model and its focus on luxury and import vehicles for diversified growth. We'll examine how Barclays' positive rating could influence Penske Automotive Group's investment narrative, particularly regarding its premium market positioning. Uncover the next big thing with...

Phillips 66 saw renewed investor attention after a California court rejected its bid to overturn an $833 million judgment concerning trade secret use from a failed Propel Fuels acquisition. The legal ruling carries both financial and reputational weight for Phillips 66. See our latest analysis for Phillips 66. Despite the legal setback, Phillips 66’s share price has held up remarkably well, gaining 12.5% over the past three months and posting a year-to-date price return of 20.6%. Momentum has...

Western Digital recently reported strong first-quarter earnings, initiated a buyback of 9.2 million shares for US$702.41 million, and raised its quarterly dividend by 25% to US$0.125 per share, to be paid in December 2025. In addition, the company announced that Brad Feller will become Chief Accounting Officer in mid-November 2025, highlighting ongoing changes to its executive team as it executes on growth plans. We’ll now examine how Western Digital’s robust earnings growth and capital...

Agnico Eagle Mines (NYSE:AEM) just turned in another record-setting quarter, showcasing impressive production and tight cost management. These results, powered by positive exploration and strong project progress, seem to be drawing fresh attention to the stock. See our latest analysis for Agnico Eagle Mines. Momentum has really kicked in for Agnico Eagle Mines, with shares climbing 3.1% on the day and soaring over 111% year-to-date as total shareholder return hits a standout 131% for the past...

Helios Technologies (HLIO) shares have seen some shifts lately, prompting investors to take a fresh look at the company’s valuation. In the past month, the stock price has gained 9%, reflecting renewed interest. See our latest analysis for Helios Technologies. Helios Technologies’ 1-month share price return of 9.2% stands out, especially after a choppy week, and builds on steady year-to-date momentum. Over the longer term, its total shareholder returns have been more modest. This suggests...

F5 recently disclosed that a nation-state threat actor gained unauthorized access to certain internal systems, exfiltrating portions of BIG-IP source code and information about undisclosed vulnerabilities, including details from its product development environment. This incident comes amid expanding security collaborations with CrowdStrike and NVIDIA, underscoring both heightened cybersecurity risks and the company’s increasing role in safeguarding enterprise-critical AI and application...

Wondering if Scholar Rock Holding could be an undervalued opportunity or if the recent excitement is just noise? You're not alone. Let's dig in and see what the numbers are really saying. The stock has been on a bit of a rollercoaster lately, climbing 10.1% over the last week but still down 30.2% year-to-date, while delivering an impressive 240.6% return over the last three years. Recent headlines have focused on Scholar Rock's collaboration updates and clinical progress, both fueling...